白内障手術後の炎症治療の世界市場レポート 2025年

白内障手術後の炎症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5％で64億米ドルに成長します。予測期間の成長は、外傷治療へのアクセス向上、先進ドラッグデリバリーシステムの利用可能性向上、併用療法の増加、糖尿病と眼合併症の発生率上昇、眼科における個別化医療の利用拡大などに起因すると考えられます。この期間の主な動向には、手術手技の発展、最先端のドラッグデリバリーシステムの採用、併用療法の開発、革新的な抗炎症治療、AIとデジタルヘルスの統合などがあります。

外傷性傷害の発生増加は、白内障手術後の炎症治療市場の成長を促進すると予想されます。外傷性損傷とは、事故、転倒、暴力、スポーツによる衝撃などの外力によって引き起こされる突発的な身体的危害のことで、軽度の切り傷から重度の骨折、火傷、脳損傷、脊髄損傷までさまざまなものがあります。外傷性傷害の増加の要因としては、交通事故の増加、職場での危険、スポーツ関連の事件、暴力、自然災害、転倒しやすくなった高齢化などが挙げられます。白内障手術後の炎症治療は、眼球の炎症を抑え、痛みを和らげ、視力回復の妨げとなる合併症を予防することで、外傷の管理に役立ちます。例えば、2023年12月、米国の政府機関である労働統計局は、米国における死亡労働災害が2022年には5,486件に上り、2021年の5,190件から5.7％増加したと報告し、労働災害の大幅な増加を浮き彫りにしました。この増加傾向は、白内障手術後の炎症治療に対する需要の高まりをさらに強調しています。

白内障手術後の炎症治療市場の主要企業は、治療成績を改善し患者の回復を高めるために、併用療法などの革新的アプローチの開発に注力しています。併用療法とは、2種類以上の薬剤や治療戦略を併用することで、より優れた治療効果を上げ、炎症を抑え、感染を予防し、早期回復をサポートするものです。例えば、2022年8月、参天製薬株式会社（本社：東京都港区、代表取締役社長：小林健）は、日本発の抗がん剤である抗てんかん剤（一般名：エリスロポエチン）を発売しました。日本を拠点とする参天製薬株式会社は2022年8月、白内障手術後のケアを改善するため、英国とアイルランドでデュクレッサを導入しました。このレボフロキサシンとデキサメタゾンの合剤は、感染症の予防と炎症の軽減に役立ち、より効果的な回復を保証します。この治療は7日間のレジメンで行うように設計されており、患者の利便性とアドヒアランスを高める。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界白内障手術後の炎症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の白内障手術後の炎症治療市場：成長率分析
• 世界の白内障手術後の炎症治療市場の実績：規模と成長, 2019-2024
• 世界の白内障手術後の炎症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界白内障手術後の炎症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の白内障手術後の炎症治療市場：薬剤クラス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブロムフェナク
• インドメタシン
• ジクロフェナク
• フルルビプロフェン
• ネパフェナク
• 世界の白内障手術後の炎症治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 注射剤
• 世界の白内障手術後の炎症治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の白内障手術後の炎症治療市場ブロムフェナクの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ブロムフェナク点眼液0.07%
• ブロムフェナク点眼液0.09%
• ブロムフェナクとの併用療法
• 世界の白内障手術後の炎症治療市場インドメタシンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• インドメタシン点眼液0.1%
• インドメタシン経口カプセル
• インドメタシン坐剤
• 世界の白内障手術後の炎症治療市場ジクロフェナクの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ジクロフェナク点眼液0.1%
• ジクロフェナク経口錠
• ジクロフェナクゲルおよび局所製剤
• 世界の白内障手術後の炎症治療市場フルルビプロフェンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フルルビプロフェン点眼液0.03%
• 眼科手術における補助的使用
• フルルビプロフェンとの併用療法
• 世界の白内障手術後の炎症治療市場ネパフェナクの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ネパフェナク点眼液0.1%
• ネパフェナク点眼液0.3%

第7章 地域別・国別分析

• 世界の白内障手術後の炎症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の白内障手術後の炎症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 白内障手術後の炎症治療市場：競合情勢
• 白内障手術後の炎症治療市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG. Overview, Products and Services, Strategy and Financial Analysis
  • Alcon Inc Overview, Products and Services, Strategy and Financial Analysis
  • Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bausch & Lomb Incorporated
• Santen Pharmaceutical Co. Ltd.
• Mallinckrodt plc
• Bio-Tissue Inc.
• Ocular Therapeutix Inc.
• Oculis Holding AG
• Senju Pharmaceutical Co. Ltd.
• NTC Srl
• EyePoint Pharmaceuticals Inc
• ImprimisRx LLC
• Eyenovia Inc.
• Formosa Pharmaceuticals Inc
• Nicox S.A.
• Surface Ophthalmics Inc.
• VivaVision Biotech Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 白内障手術後の炎症治療市場2029：新たな機会を提供する国
• 白内障手術後の炎症治療市場2029：新たな機会を提供するセグメント
• 白内障手術後の炎症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Post-operative cataract surgery inflammation treatment involves medical interventions designed to manage inflammation and discomfort following cataract surgery. These medications help control inflammation, reduce the risk of complications such as rebound iritis and pseudophakic cystoid macular edema (PCME), and support a quicker recovery.

The primary drug classes for treating post-operative inflammation following cataract surgery include bromfenac, indomethacin, diclofenac, flurbiprofen, and nepafenac. Bromfenac, a powerful NSAID used in ophthalmology, helps alleviate post-operative pain and inflammation by inhibiting COX-1 and COX-2 enzymes. These medications are available in various formulations, including oral and injectable forms, and are distributed through diverse channels such as hospital pharmacies, online pharmacies, and retail pharmacies.

The post-operative cataract surgery inflammation treatment market research report is one of a series of new reports from The Business Research Company that provides post-operative cataract surgery inflammation treatment market statistics, including the post-operative cataract surgery inflammation treatment industry global market size, regional shares, competitors with the post-operative cataract surgery inflammation treatment market share, detailed post-operative cataract surgery inflammation treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the post-operative cataract surgery inflammation treatment industry. This post-operative cataract surgery inflammation treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The post-operative cataract surgery inflammation treatment market size has grown strongly in recent years. It will grow from $4.44 billion in 2024 to $4.79 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth during the historic period can be attributed to an aging population, greater awareness of post-operative complications, a higher prevalence of ocular disorders, increased demand for effective treatments, and advancements in surgical techniques and lens implants.

The post-operative cataract surgery inflammation treatment market size is expected to see strong growth in the next few years. It will grow to $6.40 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The projected growth in the forecast period can be attributed to better access to treatment for traumatic injuries, increased availability of advanced drug delivery systems, the growing use of combination therapies, a rise in the incidence of diabetes and ocular comorbidities, and the expanding use of personalized medicine in ophthalmology. Key trends during this period include advancements in surgical techniques, the adoption of cutting-edge drug delivery systems, the development of combination therapies, innovative anti-inflammatory treatments, and the integration of AI and digital health.

The increasing occurrence of traumatic injuries is expected to drive the growth of the post-operative cataract surgery inflammation treatment market. Traumatic injuries are sudden physical harm caused by external forces such as accidents, falls, violence, or impacts from sports, and can range from minor cuts to severe fractures, burns, brain injuries, and spinal damage. Factors contributing to the rise in traumatic injuries include more road traffic accidents, workplace hazards, sports-related incidents, violence, natural disasters, and an aging population more susceptible to falls. Post-operative cataract surgery inflammation treatments help manage traumatic injuries by reducing ocular inflammation, alleviating pain, and preventing complications that could hinder visual recovery. For example, in December 2023, the Bureau of Labor Statistics, a US-based government agency, reported that fatal work injuries in the United States rose to 5,486 in 2022, a 5.7% increase from 5,190 in 2021, highlighting a significant rise in industrial accidents. This upward trend further emphasizes the growing demand for post-operative cataract surgery inflammation treatments.

Leading companies in the post-operative cataract surgery inflammation treatment market are focused on developing innovative approaches such as combination therapies to improve treatment outcomes and enhance patient recovery. Combination therapy involves using two or more medications or treatment strategies together to achieve better therapeutic results, helping reduce inflammation, prevent infection, and support faster recovery. For example, in August 2022, Santen Pharmaceutical Co. Ltd., a Japan-based company, introduced Ducressa in the UK and Ireland to improve post-cataract surgery care. This fixed-dose combination of levofloxacin and dexamethasone helps prevent infections and reduce inflammation, ensuring more effective recovery. The treatment is designed to be followed with a seven-day regimen, enhancing patient convenience and adherence.

In September 2024, Armistice Capital LLC, a US-based home healthcare service company, acquired Eyenovia Inc. for an undisclosed amount. With this acquisition, Armistice Capital LLC aims to increase its influence over Eyenovia's strategic direction and capitalize on potential growth opportunities within the ophthalmic sector. Eyenovia Inc., a US-based pharmaceutical company, specializes in treating post-operative inflammation and pain after ocular surgery using clobetasol.

Major players in the post-operative cataract surgery inflammation treatment market are Pfizer Inc., Merck & Co. Inc., Novartis AG., Alcon Inc, Sun Pharmaceutical Industries Limited, Bausch & Lomb Incorporated, Santen Pharmaceutical Co. Ltd., Mallinckrodt plc, Bio-Tissue Inc., Ocular Therapeutix Inc., Oculis Holding AG, Senju Pharmaceutical Co. Ltd., NTC Srl, EyePoint Pharmaceuticals Inc, ImprimisRx LLC, Eyenovia Inc., Formosa Pharmaceuticals Inc, Nicox S.A., Surface Ophthalmics Inc., VivaVision Biotech Inc.

North America was the largest region in the post-operative cataract surgery inflammation treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in post-operative cataract surgery inflammation treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the post-operative cataract surgery inflammation treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The post-operative cataract surgery inflammation treatment market consists of sales of corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and anti-inflammatory medications. Values in this market are 'factory gate' values, meaning the value of goods sold by manufacturers, whether to other entities (including wholesalers, distributors, or directly to end customers) or downstream manufacturers. The value of goods includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Post-Operative Cataract Surgery Inflammation Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on post-operative cataract surgery inflammation treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for post-operative cataract surgery inflammation treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The post-operative cataract surgery inflammation treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Bromfenac; Indomethacin; Diclofenac; Flurbiprofen; Nepafenac
• 2) By Route of Administration: Oral; Injectable
• 3) By Distribution Channel: Hospital pharmacy; Online Pharmacy; Retail pharmacy
• Subsegments:
• 1) By Bromfenac: Bromfenac Ophthalmic Solution 0.07%; Bromfenac Ophthalmic Solution 0.09%; Combination Therapies With Bromfenac
• 2) By Indomethacin: Indomethacin Ophthalmic Solution 0.1%; Indomethacin Oral Capsules; Indomethacin Suppositories
• 3) By Diclofenac: Diclofenac Ophthalmic Solution 0.1%; Diclofenac Oral Tablets; Diclofenac Gel and Topical Formulations
• 4) By Flurbiprofen: Flurbiprofen Ophthalmic Solution 0.03%; Adjunctive Use In Ocular Surgery; Combination Therapies With Flurbiprofen
• 5) By Nepafenac: Nepafenac Ophthalmic Suspension 0.1%; Nepafenac Ophthalmic Suspension 0.3%
• Companies Mentioned:Pfizer Inc.; Merck & Co. Inc.; Novartis AG.; Alcon Inc; Sun Pharmaceutical Industries Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Post-Operative Cataract Surgery Inflammation Treatment Market Characteristics

3. Post-Operative Cataract Surgery Inflammation Treatment Market Trends And Strategies

4. Post-Operative Cataract Surgery Inflammation Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Post-Operative Cataract Surgery Inflammation Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Post-Operative Cataract Surgery Inflammation Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Post-Operative Cataract Surgery Inflammation Treatment Market Growth Rate Analysis
• 5.4. Global Post-Operative Cataract Surgery Inflammation Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Post-Operative Cataract Surgery Inflammation Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Post-Operative Cataract Surgery Inflammation Treatment Total Addressable Market (TAM)

6. Post-Operative Cataract Surgery Inflammation Treatment Market Segmentation

• 6.1. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bromfenac
• Indomethacin
• Diclofenac
• Flurbiprofen
• Nepafenac
• 6.2. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• 6.3. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital pharmacy
• Online Pharmacy
• Retail pharmacy
• 6.4. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Sub-Segmentation Of Bromfenac, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bromfenac Ophthalmic Solution 0.07%
• Bromfenac Ophthalmic Solution 0.09%
• Combination Therapies With Bromfenac
• 6.5. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Sub-Segmentation Of Indomethacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Indomethacin Ophthalmic Solution 0.1%
• Indomethacin Oral Capsules
• Indomethacin Suppositories
• 6.6. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Sub-Segmentation Of Diclofenac, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diclofenac Ophthalmic Solution 0.1%
• Diclofenac Oral Tablets
• Diclofenac Gel and Topical Formulations
• 6.7. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Sub-Segmentation Of Flurbiprofen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flurbiprofen Ophthalmic Solution 0.03%
• Adjunctive Use In Ocular Surgery
• Combination Therapies With Flurbiprofen
• 6.8. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Sub-Segmentation Of Nepafenac, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nepafenac Ophthalmic Suspension 0.1%
• Nepafenac Ophthalmic Suspension 0.3%

7. Post-Operative Cataract Surgery Inflammation Treatment Market Regional And Country Analysis

• 7.1. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Post-Operative Cataract Surgery Inflammation Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Post-Operative Cataract Surgery Inflammation Treatment Market

• 8.1. Asia-Pacific Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Post-Operative Cataract Surgery Inflammation Treatment Market

• 9.1. China Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 9.2. China Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Post-Operative Cataract Surgery Inflammation Treatment Market

• 10.1. India Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Post-Operative Cataract Surgery Inflammation Treatment Market

• 11.1. Japan Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 11.2. Japan Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Post-Operative Cataract Surgery Inflammation Treatment Market

• 12.1. Australia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Post-Operative Cataract Surgery Inflammation Treatment Market

• 13.1. Indonesia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Post-Operative Cataract Surgery Inflammation Treatment Market

• 14.1. South Korea Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 14.2. South Korea Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Post-Operative Cataract Surgery Inflammation Treatment Market

• 15.1. Western Europe Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 15.2. Western Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Post-Operative Cataract Surgery Inflammation Treatment Market

• 16.1. UK Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Post-Operative Cataract Surgery Inflammation Treatment Market

• 17.1. Germany Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Post-Operative Cataract Surgery Inflammation Treatment Market

• 18.1. France Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Post-Operative Cataract Surgery Inflammation Treatment Market

• 19.1. Italy Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Post-Operative Cataract Surgery Inflammation Treatment Market

• 20.1. Spain Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Post-Operative Cataract Surgery Inflammation Treatment Market

• 21.1. Eastern Europe Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 21.2. Eastern Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Post-Operative Cataract Surgery Inflammation Treatment Market

• 22.1. Russia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Post-Operative Cataract Surgery Inflammation Treatment Market

• 23.1. North America Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 23.2. North America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Post-Operative Cataract Surgery Inflammation Treatment Market

• 24.1. USA Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 24.2. USA Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Post-Operative Cataract Surgery Inflammation Treatment Market

• 25.1. Canada Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 25.2. Canada Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Post-Operative Cataract Surgery Inflammation Treatment Market

• 26.1. South America Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 26.2. South America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Post-Operative Cataract Surgery Inflammation Treatment Market

• 27.1. Brazil Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Post-Operative Cataract Surgery Inflammation Treatment Market

• 28.1. Middle East Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 28.2. Middle East Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Post-Operative Cataract Surgery Inflammation Treatment Market

• 29.1. Africa Post-Operative Cataract Surgery Inflammation Treatment Market Overview
• 29.2. Africa Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Post-Operative Cataract Surgery Inflammation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Post-Operative Cataract Surgery Inflammation Treatment Market Competitive Landscape And Company Profiles

• 30.1. Post-Operative Cataract Surgery Inflammation Treatment Market Competitive Landscape
• 30.2. Post-Operative Cataract Surgery Inflammation Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Alcon Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sun Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

31. Post-Operative Cataract Surgery Inflammation Treatment Market Other Major And Innovative Companies

• 31.1. Bausch & Lomb Incorporated
• 31.2. Santen Pharmaceutical Co. Ltd.
• 31.3. Mallinckrodt plc
• 31.4. Bio-Tissue Inc.
• 31.5. Ocular Therapeutix Inc.
• 31.6. Oculis Holding AG
• 31.7. Senju Pharmaceutical Co. Ltd.
• 31.8. NTC Srl
• 31.9. EyePoint Pharmaceuticals Inc
• 31.10. ImprimisRx LLC
• 31.11. Eyenovia Inc.
• 31.12. Formosa Pharmaceuticals Inc
• 31.13. Nicox S.A.
• 31.14. Surface Ophthalmics Inc.
• 31.15. VivaVision Biotech Inc.

32. Global Post-Operative Cataract Surgery Inflammation Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Post-Operative Cataract Surgery Inflammation Treatment Market

34. Recent Developments In The Post-Operative Cataract Surgery Inflammation Treatment Market

35. Post-Operative Cataract Surgery Inflammation Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Post-Operative Cataract Surgery Inflammation Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Post-Operative Cataract Surgery Inflammation Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Post-Operative Cataract Surgery Inflammation Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer